Unveiling the significant breakthroughs in veterinary diagnostics, QL biotech has emerged as a trailblazer in innovative research and product development. The company has heavily invested in the discovery and design of diverse diagnostic tools with a special focus on the detection of canine NT-proBNP.
The QL biotech team's efforts are geared towards improving the overall health and welfare of canines. They have developed an advanced diagnostic tool for the detection of canine NT-proBNP, which exhibits their commitment to revolutionize veterinary medicine.
The detection of canine NT-proBNP is a critical parameter in diagnosing heart diseases in dogs. An elevated level of this biomarker indicates cardiac stress, enabling veterinarians to identify heart conditions at an early stage. With QL biotech's test device, timely diagnosis has become more achievable, giving countless dogs a fighting chance against heart disease.
QL biotech’s notable range of products extends far beyond canine health. Their offerings exhibit an unwavering commitment to making significant contributions in human healthcare as well. This includes their Wholesale Human Immunodeficiency Virus (HIV) Ab & P24 Ag Rapid Test Device, an essential tool for the early detection of HIV. Also, their HIV 1&2 Human Immunodeficiency Virus Rapid Test Strip/Device has proven instrumental in HIV detection and management.
For women's health, QL biotech has developed the Wholesale iGFBP-1 Rapid Test Device/Strip, specifically designed to examine vaginal secretions. Their Human Fecal Occult Blood (FOB) Rapid Test Device is an essential tool for colorectal cancer screening.
In terms of cardiac care, the company offers the Wholesale CK‐MB Rapid Test Device. This device aids in identifying possible heart attacks by measuring the levels of Creatine Kinase-MB, a protein released into the blood after a heart attack.
QL biotech’s impressive product portfolio is a testament to their profound expertise and extensive experience in product development and production within the IVD industry. Their R&D team has over 20 years of experience, ensuring that each product they develop is innovative, reliable, and invaluable in practical healthcare applications.
In a nutshell, QL biotech continues to outshine as a manufacturer and supplier of necessary diagnostic tools, both in human and veterinary healthcare. Their contributions to the detection of canine NT-proBNP have not only improved the accuracy of heart disease detection in canines but also paved the way for further research and development in the field of veterinary diagnostics. With QL biotech at the helm, the future of diagnostics looks brighter than ever before.
Post time: 2024-03-05 13:28:12